These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22508804)

  • 1. A selective cytopheretic inhibitory device for use during cardiopulmonary bypass surgery.
    Pino CJ; Lou L; Smith PL; Ding F; Pagani FD; Buffington DA; Humes HD
    Perfusion; 2012 Jul; 27(4):311-9. PubMed ID: 22508804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cytopheretic inhibitory device with regional citrate anticoagulation and portable sorbent dialysis.
    Pino CJ; Farokhrani A; Lou L; Smith PL; Johnston K; Buffington DA; Humes HD
    Artif Organs; 2013 Feb; 37(2):203-10. PubMed ID: 23067378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic leukocyte filtration during cardiopulmonary bypass.
    Fabbri A; Manfredi J; Piccin C; Soffiati G; Carta MR; Gasparotto E; Nardon G
    Perfusion; 2001 Mar; 16 Suppl():11-8. PubMed ID: 11334202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The dynamics of blood composition changes in leukocyte filtration during cardiopulmonary bypass. Preliminary results].
    Mihaljevic T; Tönz M; Pasic M; Engel M; von Segesser LK; Turina M
    Helv Chir Acta; 1993 Dec; 60(3):403-6. PubMed ID: 8119822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability.
    Partrick DA; Moore EE; Fullerton DA; Barnett CC; Meldrum DR; Silliman CC
    J Surg Res; 1999 Sep; 86(1):42-9. PubMed ID: 10452867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the inflammatory response between miniaturized and standard CPB circuits in aortic valve surgery.
    Bical OM; Fromes Y; Gaillard D; Fischer M; Ponzio O; Deleuze P; Gerhardt MF; Trivin F
    Eur J Cardiothorac Surg; 2006 May; 29(5):699-702. PubMed ID: 16520053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass.
    Olivencia-Yurvati AH; Ferrara CA; Tierney N; Wallace N; Mallet RT
    Perfusion; 2003 Mar; 18 Suppl 1():23-31. PubMed ID: 12708762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass.
    Ilmakunnas M; Pesonen EJ; Ahonen J; Rämö J; Siitonen S; Repo H
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):851-9. PubMed ID: 15821654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response.
    Bourbon A; Vionnet M; Leprince P; Vaissier E; Copeland J; McDonagh P; Debré P; Gandjbakhch I
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):932-8. PubMed ID: 15519185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammatory response syndrome is reduced by preoperative plasma-thrombo-leukocyte aphaeresis in a pig model of cardiopulmonary bypass.
    Wagner R; Piler P; Uchytil B; Halouzka R; Kovaru H; Bobkova M; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):399-406. PubMed ID: 27049532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Leukocyte Modulator Device Reduces the Inflammatory Response to Cardiopulmonary Bypass.
    Johnston KA; Westover AJ; Rojas-Pena A; Haft JW; Toomasian JM; Johnson T; Buffington DA; Humes HD
    ASAIO J; 2019; 65(4):401-407. PubMed ID: 29863627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock.
    Kumagai T; Takeyama N; Yabuki T; Harada M; Miki Y; Kanou H; Inoue S; Nakagawa T; Noguchi H
    Shock; 2010 Nov; 34(5):461-6. PubMed ID: 20386499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a miniaturized circuit and an asanguineous prime to reduce neutrophil-mediated organ dysfunction following infant cardiopulmonary bypass.
    Karamlou T; Schultz JM; Silliman C; Sandquist C; You J; Shen I; Ungerleider RM
    Ann Thorac Surg; 2005 Jul; 80(1):6-13; discussion 13-4. PubMed ID: 15975331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pulmonary protective effects of leukocyte depletion with a modified filter located at the cardiopulmonary bypass (CPB) venous line in canine].
    Li Q; Chen HJ; Du L; Zhou L; Wang Y; Liu B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):723-6. PubMed ID: 16235549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary bypass-induced inflammation: is it important?
    Hill GE
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rat model of cardiopulmonary bypass with cardioplegic arrest and hemodynamic assessment by conductance catheter technique.
    Günzinger R; Wildhirt SM; Schad H; Heimisch W; Gurdan M; Mendler N; Grammer J; Lange R; Bauernschmitt R
    Basic Res Cardiol; 2007 Nov; 102(6):508-17. PubMed ID: 17668258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass.
    Abacilar F; Dogan OF; Duman U; Ucar I; Demircin M; Ersoy U; Dogan R; Boke E
    Heart Surg Forum; 2006; 9(4):E703-9. PubMed ID: 16844625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical heparin coated cardiopulmonary bypass: reduction of systemic heparin requirements for redo cardiac surgery.
    Ladowski JS; Schatzlein MH; Peterson AC; Deschner WP; Matheis R; Ellenwood M; Bach J; Moldovan L; McKamey D
    ASAIO J; 1996; 42(1):34-6. PubMed ID: 8808455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.